VanEck Biotech ETF
BBH
80 hedge funds and large institutions have $161M invested in VanEck Biotech ETF in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 5 closing their positions.
425% more call options, than puts
Call options by funds: $6.2M | Put options by funds: $1.18M
88% more capital invested
Capital invested by funds: $85.6M → $161M (+$75.5M)
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
10.85% more ownership
Funds ownership: 15.56% → 26.41% (+11%)
3% more funds holding
Funds holding: 78 → 80 (+2)
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$68.1M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$2.92M |
| 3 |
SG Americas Securities
New York
|
+$2.5M |
| 4 |
Nomura Asset Management
Tokyo,
Japan
|
+$1.06M |
| 5 |
Jane Street
New York
|
+$900K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$3.38M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.16M |
| 3 |
Truist Financial
Charlotte,
North Carolina
|
-$914K |
| 4 |
Millennium Management
New York
|
-$834K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$676K |
BBH Hedge Fund Activity: Q3 2016 in Review
80 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2016, worth a combined $161M — up 88% from $85.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BBH positions and 5 closed out — a net gain of 3 holders — while 26 added to existing stakes and 25 trimmed.
The largest buyer was AllianceBernstein, opening a new position worth an estimated $68.1M. The largest seller was Virtu Financial, exiting entirely with an estimated $3.38M sold.
- 80 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2016, up from 78 in Q2 2016.
- Funds reported $161M of VanEck Biotech ETF stock for Q3 2016, up 88% quarter-over-quarter.
- 8 funds opened new VanEck Biotech ETF positions in Q3 2016 and 5 closed out, a net change of +3 holders.
- The largest VanEck Biotech ETF buyer in Q3 2016 was AllianceBernstein, an estimated $68.1M added.
- The largest VanEck Biotech ETF seller in Q3 2016 was Virtu Financial, an estimated $3.38M sold.
Based on aggregated 13F filings for Q3 2016.